Agenerase and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Agenerase (amprenavir) and Acyclovir (acyclovir). Common drug interactions include diarrhoea among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Agenerase and Acyclovir. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Agenerase?

Agenerase has active ingredients of amprenavir. eHealthMe is studying from 1,117 Agenerase users. Check the latest studies of Agenerase.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.



On Aug, 05, 2026

57 people who take Agenerase and Acyclovir together, and have interactions are studied.

Agenerase and Acyclovir drug interactions.

What are the common drug interactions of Agenerase and Acyclovir, by gender? *:

female:

  1. Diarrhoea
  2. Dysgeusia (disorder of the sense of taste)
  3. Nausea (feeling of having an urge to vomit)
  4. Pancreatitis (inflammation of pancreas)
  5. Vomiting

male:

  1. Pyrexia (fever)
  2. Nausea (feeling of having an urge to vomit)
  3. International normalised ratio increased
  4. Peripheral neuropathy (damage to nerves of the peripheral nervous system)
  5. Sweating increased (excess sweating)
  6. Tinnitus (a ringing in the ears)
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Blood creatinine increased
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the common drug interactions of Agenerase and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pancreatitis (inflammation of pancreas)

30-39:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Chest pain
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. International normalised ratio increased
  5. Pyrexia (fever)
  6. Epistaxis (bleed from the nose)
  7. Hypotension (abnormally low blood pressure)
  8. Abnormal behaviour
  9. Agitation (state of anxiety or nervous excitement)
  10. Bipolar disorder (mood disorder)

40-49:

  1. Dysarthria (speech disorder)
  2. Dysgeusia (disorder of the sense of taste)
  3. Dyspnoea (difficult or laboured respiration)
  4. Eye irritation
  5. Facial palsy (paralysis of face nerve)
  6. Gynaecomastia (enlargement of the gland tissue of the male breast)
  7. Haematocrit decreased
  8. Hemiparesis (weakness on one side of the body)
  9. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  10. Hypercholesterolaemia (high levels of cholesterol in the blood)

50-59:

  1. Pyrexia (fever)
  2. Drug hypersensitivity
  3. Myalgia (muscle pain)
  4. Nausea (feeling of having an urge to vomit)
  5. Dyspnoea (difficult or laboured respiration)
  6. Hypersensitivity
  7. Lethargy (tiredness)
  8. Rash macular (small, flat red spots)
  9. Vomiting
  10. Abdominal pain upper

60+:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Blood chloride decreased
  3. Nausea (feeling of having an urge to vomit)
  4. Sedation
  5. Weight decreased
  6. Blood lactate dehydrogenase increased
  7. Confusion
  8. Dysgeusia (disorder of the sense of taste)
  9. Headache (pain in head)
  10. Hypertension (high blood pressure)

* Approximation only. Some reports may have incomplete information.

Do you take Agenerase and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Agenerase and Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Agenerase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Agenerase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amprenavir and acyclovir (the active ingredients of Agenerase and Acyclovir, respectively), and Agenerase and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: